Arbor Biotechnologies® - Home
网页At Arbor® Biotech, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.
We Are - Arbor Biotechnologies®
网页At Arbor, we envision a world free of disease by using genetic medicines to fundamentally shift the paradigm from treatment to functional cure, and ultimately to prevention. We aim to accomplish this through the discovery of programmable DNA editors with the power to enable bespoke curative genetic medicines for patients.
Arbor Biotechnologies Announces Acquisition of Serendipity
网页Serendipity brings proprietary gene editing assets from the lab of gene editing pioneer Feng Zhang, bolstering Arbor’s diverse toolbox of novel, next-generation editors and expanding potential therapeutic applications in reverse transcriptase-based editing and insertion of large regions of DNA.
Arbor Biotechnologies Closes $215 Million Oversubscribed
网页2021年11月9日 · Arbor Biotechnologies is a life sciences company discovering and developing the next generation of genetic medicines based on wholly owned genomic editors discovered from its machine...
Arbor Biotechnologies - LinkedIn
网页Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic...
Arbor Biotechnologies Closes $215 Million Oversubscribed Series …
网页2021年11月9日 · Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next-Generation Precision Editing Therapeutics. The most extensive toolbox of proprietary genomic editors...
Arbor Biotechnologies Enters into Agreement with Acuitas
网页2022年8月25日 · Arbor Biotechnologies is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines.
Arbor Biotechnologies Announces Acquisition of Serendipity - Yahoo Finance
网页2024年5月8日 · Arbor Biotechnologies Inc. Serendipity brings proprietary gene editing assets from the lab of gene editing pioneer Feng Zhang, bolstering Arbor’s diverse toolbox of novel, next-generation ...
Our Pipeline - Arbor Biotechnologies®
网页Why Liver & CNS Disease. Since our founding, we have developed a wholly owned portfolio of editing technologies that can be used to create in vivo targeted genetic medicines, beginning with the liver and CNS.
Arbor Biotechnologies Presents Data Supporting Clinical
网页2024年5月9日 · Preclinical data shared in a poster presentation confirm that novel type V nucleases, discovered and optimized using Arbor’s discovery platform, can prevent aberrant splicing of STMN2,...
- 某些结果已被删除